![American Gastroenterological Association American Gastroenterological Association](https://54d4f314-8f94-415c-acb7-fd0a6332f070.s3.amazonaws.com/374/374__aga-logo-lg__-1706585740.png?X-Amz-Content-Sha256=UNSIGNED-PAYLOAD&X-Amz-Algorithm=AWS4-HMAC-SHA256&X-Amz-Credential=AKIAU2BE4PNFKE2WZV7V%2F20240727%2Fus-east-1%2Fs3%2Faws4_request&X-Amz-Date=20240727T021510Z&X-Amz-SignedHeaders=host&X-Amz-Expires=86400&X-Amz-Signature=abd95cd1f9a249a1106c159a032c94d1083a920371818b714fd819834ec7aa4e)
Adult Obesity — Pharmacological Interventions
Publication Date: October 20, 2022
Key Points
Key Points
- The prevalence of obesity in the United States has increased dramatically over the past few decades from 30.5% in 1999–2000 to 41.9% in 2019–2020.
- In adults, obesity-related complications such as cardiovascular disease, stroke, type 2 diabetes mellitus (T2DM), nonalcoholic steatohepatitis, obstructive sleep apnea, osteoarthritis, and certain types of cancer (e.g., colorectal cancer) have also increased, contributing to high morbidity and mortality.
- Lifestyle intervention(s) has limited effectiveness and durability for most individuals.
- Pharmacological therapies with high efficacy in achieving weight loss have seen limited use, partly due to lack of familiarity and limited insurance coverage.
- A small number of providers are responsible for >90% of the anti-obesity medication prescriptions.
Treatment
...eatment...
...dults with obesity or overweight with...
...In adults with obesity or overwei...
...h obesity or overweight with weight-related comp...
...ts with obesity or overweight with...
...dults with obesity or overweight with weight-relat...
...lts with obesity or overweight with weight-r...
...ts with obesity or overweight with weight-rela...
...ts with obesity or overweight with weig...
...with body mass index (BMI) between 25 and...
.... Anti-obesity MedicationsHaving trouble vi...
...ure 1. Pharmacological Interventio...